Tali Digital Ltd
ASX:TD1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Suchitra Finance & Trading Co Ltd
BSE:538714
|
IN |
|
K
|
Kao Corp
XBER:KAO
|
JP |
|
J
|
Jiangxi Sunshine Dairy Co Ltd
SZSE:001318
|
CN |
Tali Digital Ltd
Research & Development
Tali Digital Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tali Digital Ltd
ASX:TD1
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Research & Development
-AU$568.2k
|
CAGR 3-Years
54%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pro Medicus Ltd
ASX:PME
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Tali Digital Ltd
Glance View
Tali Digital Ltd. engages in the development and commercialization of products in the emerging health technology sector. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-23. The firm is engaged in early childhood technology business targeting in children through its Tali platform. The firm has built a platform technology, the first iteration of which targets cognitive attention skills during early childhood through its video-gamed-based TALi screening (DETECT) and training (TRAIN). TALi are a software as a service (SaaS) model delivered via business to business (B2B) partnership and licensing models globally. The firm is engaged in delivering a series of product developments in ADHD (Attention Deficit Hyperactivity Disorder) and ASD (Autism Spectrum Disorder) for predictive diagnosis and treatment for all age groups along with a core research program exploring applications for at populations afflicted with Mild Cognitive Decline (MCI), which has been found to often been a precursor to recognizing Alzheimer’s disease and other forms of dementia.
